GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Design of MEK Inhibitor Regimens for the Treatment of Pancreatic Cancer

$376,406
Judith S Leopold · University Of Michigan At Ann Arbor · R01 · FY2016 · CA

Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures

$376,399
Richard L. Klemke · University Of California, San Diego · R01 · FY2017 · CA

Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures

$376,399
Richard L. Klemke · University Of California, San Diego · R01 · FY2018 · CA

Novel mechanisms in ER regulation in heart

$376,385
Yibin Wang · University Of California Los Angeles · R01 · FY2008 · HL

Novel mechanisms in ER regulation in heart

$376,385
Yibin Wang · University Of California Los Angeles · R01 · FY2007 · HL

Dorsal-Ventral Pattern Formation in the Zebrafish Embryo

$376,373
Mary C Mullins · University Of Pennsylvania · R01 · FY2012 · GM

Role of CDK4 in Cell Cycle Progression and Cancer

$376,250
Temple University · R01 · FY2003 · AG

Role of CDK4 in Cell Cycle Progression and Cancer

$376,250
Temple University · R01 · FY2005 · AG

Role of CDK4 in Cell Cycle Progression and Cancer

$376,250
Temple University · R01 · FY2004 · AG

Role of CDK4 in Cell Cycle Progression and Cancer

$376,250
Temple University · R01 · FY2002 · AG

A fortified lipid bilayer platform for improved drug packaging and therapeutic delivery

$376,151
Jianqin Lu · University Of Arizona · R35 · FY2025 · GM

A fortified lipid bilayer platform for improved drug packaging and therapeutic delivery

$376,151
Jianqin Lu · University Of Arizona · R35 · FY2024 · GM

A fortified lipid bilayer platform for improved drug packaging and therapeutic delivery

$376,151
Jianqin Lu · University Of Arizona · R35 · FY2022 · GM

A fortified lipid bilayer platform for improved drug packaging and therapeutic delivery

$376,151
Jianqin Lu · University Of Arizona · R35 · FY2023 · GM

Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma

$376,110
Nabihah Tayob · Dana-Farber Cancer Inst · R01 · FY2020 · CA

Dectin-1 signaling drives pancreatic oncogenesis by inducing macrophage-mediated adaptive immune suppression

$376,098
George Miller · New York University School Of Medicine · R01 · FY2019 · CA

Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy

$376,075
Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2022 · CA

Spread of Replicating Adenovirus in Pancreatic Tumors

$376,025
New York University School Of Medicine · R01 · FY2004 · CA

Spread of Replicating Adenovirus in Pancreatic Tumors

$376,025
New York University School Of Medicine · R01 · FY2005 · CA

Targeting DYRK1A Modulation of GLI1 for Anti-Tumor Efficacy

$375,830
Kevin Peter Williams · North Carolina Central University · R15 · FY2016 · CA

Deploying Histotripsy Based Tumor Ablation Strategies to Treat Pancreatic Cancer

$375,828
Irving C Allen · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · CA

Tumor-intrinsic and paracrine roles of endoglin in pancreatic cancer

$375,820
Nam Y Lee · University Of Arizona · R01 · FY2025 · CA

Pancreas Transcription Factors and Disease Model Systems

$375,708
Stephen F Konieczny · Purdue University · R01 · FY2010 · DK

Origins and functions of pancreatic cancer-associated fibroblasts

$375,586
Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

RTB 1

$375,521
Laura Delong Wood · Johns Hopkins University · U54 · FY2023 · CA